ArticleNucleic acids research2025
Structurally related phage helicases trigger type III-A3 retron-mediated anti-phage defense across diverse tailed phage families.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Classification of Sir2-HerA systems reveals a multilayered regulatory cascade gating the type III antiphage activity.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Retrons are tripartite bacterial systems composed of non-coding RNA (ncRNA), reverse transcriptase (RT), and effector proteins with diverse enzymatic domains. Here, we characterized Retron-Eco11, a type III-A3 retron associated with a phosphoribosyltransferase-like effector, and demonstrated that it mediates anti-phage defense and can be harnessed for genome editing. All three components-ncRNA, RT, and effector-are essential for defense. Retron-Eco11 protects Escherichia coli against multiple phages and is specifically activated by structurally related, phage-encoded helicases, including UvsW and D10 from phages T4 and T5. We show that these helicases trigger effector-mediated toxicity, leading to abortive infection, which is associated with phosphoribosyl pyrophosphate depletion due to PRTase activation, thereby altering nucleotide metabolism. UvsW interacts directly with multicopy single-stranded DNA, and effector protein activation requires the catalytic activity of phage-encoded helicases. Our data indicate that activation occurs without detectable effector release or measurable changes in the composition of the Retron complex. Beyond its defensive role, Retron-Eco11 enables targeted genome editing in bacterial and eukaryotic cells, underscoring the biological relevance and biotechnological potential of type III-A3 retrons.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.